Figure 5: DNA copy number, gene expression, and mutation distributions in lung adenocarcinomas.
From: Somatic mutations affect key pathways in lung adenocarcinoma
a–d, Copy number, gene expression and mutation status at TP53 (a), APC (b), EGFR (c) and KRAS (d) loci in 41 lung adenocarcinomas. Normalized gene expression and log2 DNA copy number ratio in each sample were determined as described in Supplementary Information.
